2024 Q2 Form 10-Q Financial Statement

#000094539424000025 Filed on May 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $512.9M $436.3M
YoY Change 1.82% 1.64%
Cost Of Revenue $328.2M $305.1M
YoY Change 6.19% 1.84%
Gross Profit $184.7M $131.2M
YoY Change -5.13% 1.17%
Gross Profit Margin 36.01% 30.07%
Selling, General & Admin $10.68M $10.51M
YoY Change -14.0% -3.71%
% of Gross Profit 5.78% 8.01%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $95.67M $93.11M
YoY Change 1.17% -6.93%
% of Gross Profit 51.8% 70.99%
Operating Expenses $111.3M $108.3M
YoY Change -0.04% -5.68%
Operating Profit $73.39M $22.83M
YoY Change -11.92% 54.37%
Interest Expense -$93.03M $91.41M
YoY Change -212.76% 12.05%
% of Operating Profit -126.77% 400.45%
Other Income/Expense, Net
YoY Change
Pretax Income -$70.61M -$72.04M
YoY Change 978.34% -372.96%
Income Tax $524.0K $1.007M
% Of Pretax Income
Net Earnings -$73.85M -$78.38M
YoY Change 554.81% -402.05%
Net Earnings / Revenue -14.4% -17.97%
Basic Earnings Per Share -$0.45 -$0.48
Diluted Earnings Per Share -$0.45 -$0.48
COMMON SHARES
Basic Shares Outstanding 165.8M shares 165.8M shares
Diluted Shares Outstanding 165.2M shares 165.2M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $14.63M $71.29M
YoY Change -96.64% -60.53%
Cash & Equivalents $14.63M $71.29M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $28.96M $21.40M
Other Receivables $70.48M $64.15M
Total Short-Term Assets $114.1M $156.8M
YoY Change -77.45% -40.22%
LONG-TERM ASSETS
Property, Plant & Equipment $6.413B $6.577B
YoY Change -3.06% 0.93%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $108.1M $111.0M
YoY Change -0.74% 2.62%
Other Assets $131.8M $24.74M
YoY Change 341.77% 48.39%
Total Long-Term Assets $7.008B $7.075B
YoY Change -1.91% -2.01%
TOTAL ASSETS
Total Short-Term Assets $114.1M $156.8M
Total Long-Term Assets $7.008B $7.075B
Total Assets $7.122B $7.232B
YoY Change -6.9% -3.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $565.1M $590.7M
YoY Change -5.05% 51.48%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $565.1M $590.7M
YoY Change -5.05% 51.48%
LONG-TERM LIABILITIES
Long-Term Debt $5.548B $5.526B
YoY Change -2.93% -3.22%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $5.548B $5.526B
YoY Change -2.93% -3.22%
TOTAL LIABILITIES
Total Short-Term Liabilities $565.1M $590.7M
Total Long-Term Liabilities $5.548B $5.526B
Total Liabilities $6.113B $6.117B
YoY Change -3.13% 0.27%
SHAREHOLDERS EQUITY
Retained Earnings $2.318B $2.392B
YoY Change -7.93% -5.42%
Common Stock $1.659M $1.658M
YoY Change 0.24% 0.18%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.009B $1.115B
YoY Change
Total Liabilities & Shareholders Equity $7.122B $7.232B
YoY Change -6.9% -3.35%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income -$73.85M -$78.38M
YoY Change 554.81% -402.05%
Depreciation, Depletion And Amortization $95.67M $93.11M
YoY Change 1.17% -6.93%
Cash From Operating Activities $43.82M -$926.0K
YoY Change -86.14% -107.48%
INVESTING ACTIVITIES
Capital Expenditures $66.12M $76.26M
YoY Change -67.05% 167.1%
Acquisitions
YoY Change
Other Investing Activities -$1.849M $1.432M
YoY Change -100.97% -99.0%
Cash From Investing Activities -$67.97M -$74.83M
YoY Change 560.42% -165.49%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -33.72M -$34.75M
YoY Change -33.95% -246.06%
NET CHANGE
Cash From Operating Activities 43.82M -$926.0K
Cash From Investing Activities -67.97M -$74.83M
Cash From Financing Activities -33.72M -$34.75M
Net Change In Cash -57.87M -$110.5M
YoY Change -122.71% -173.47%
FREE CASH FLOW
Cash From Operating Activities $43.82M -$926.0K
Capital Expenditures $66.12M $76.26M
Free Cash Flow -$22.30M -$77.19M
YoY Change -119.32% 377.11%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
334796000 usd
CY2023Q1 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/srt/2023#HotelMember
CY2024Q1 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/srt/2023#HotelMember
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
336236000 usd
CY2024Q1 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
100014000 usd
CY2023Q1 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
94413000 usd
CY2024Q1 us-gaap Revenues
Revenues
436250000 usd
CY2023Q1 us-gaap Revenues
Revenues
429209000 usd
CY2024Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
305086000 usd
CY2023Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
299566000 usd
CY2024Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
4723000 usd
CY2023Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
3905000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
93107000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
93107000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
100039000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10506000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10911000 usd
CY2024Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 usd
CY2023Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
887000 usd
CY2024Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
2451000 usd
CY2024Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
2451000 usd
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
415873000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
415308000 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
-2963000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
41898000 usd
CY2024Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
0 usd
CY2023Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
49430000 usd
CY2024Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
1962000 usd
CY2023Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
2786000 usd
CY2024Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
7226000 usd
CY2024Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
7226000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
5232000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
91414000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
81580000 usd
CY2024Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-44000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-72038000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
26391000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1007000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3780000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-5338000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-4221000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-78383000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
25950000 usd
CY2024Q1 us-gaap Oci Equity Method Investment After Tax
OciEquityMethodInvestmentAfterTax
-344000 usd
CY2023Q1 us-gaap Oci Equity Method Investment After Tax
OciEquityMethodInvestmentAfterTax
-214000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-344000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-214000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-78727000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
25736000 usd
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
165158000 shares
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
165158000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
164867000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
164867000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.48
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.48
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1226133000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-78383000 usd
CY2024Q1 us-gaap Oci Equity Method Investment After Tax
OciEquityMethodInvestmentAfterTax
-344000 usd
CY2024Q1 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
430000 usd
CY2024Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
13000 usd
CY2024Q1 us-gaap Dividends
Dividends
33154000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1114669000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1388792000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
25950000 usd
CY2023Q1 us-gaap Oci Equity Method Investment After Tax
OciEquityMethodInvestmentAfterTax
-214000 usd
CY2023Q1 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
514000 usd
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
46000 usd
CY2023Q1 svc Stock Forfeited During Period Values
StockForfeitedDuringPeriodValues
1000 usd
CY2023Q1 us-gaap Dividends
Dividends
33090000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1381905000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-78383000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
25950000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
93107000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
93107000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
100039000 usd
CY2024Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
7226000 usd
CY2024Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
7226000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
5232000 usd
CY2024Q1 us-gaap Straight Line Rent
StraightLineRent
5768000 usd
CY2023Q1 us-gaap Straight Line Rent
StraightLineRent
-2448000 usd
CY2024Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-44000 usd
CY2024Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
2451000 usd
CY2024Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
2451000 usd
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2024Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
0 usd
CY2023Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
49430000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-5338000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-4221000 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
-2963000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
41898000 usd
CY2024Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
925000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
781000 usd
CY2024Q1 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
15024000 usd
CY2023Q1 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
16889000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1801000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-4254000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-6077000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-18492000 usd
CY2024Q1 us-gaap Increase Decrease In Due To Affiliates
IncreaseDecreaseInDueToAffiliates
-4033000 usd
CY2023Q1 us-gaap Increase Decrease In Due To Affiliates
IncreaseDecreaseInDueToAffiliates
-2325000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-926000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
12373000 usd
CY2024Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
76261000 usd
CY2023Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
28551000 usd
CY2024Q1 svc Property Managers Purchases With Restricted Cash
PropertyManagersPurchasesWithRestrictedCash
1002000 usd
CY2023Q1 svc Property Managers Purchases With Restricted Cash
PropertyManagersPurchasesWithRestrictedCash
1558000 usd
CY2024Q1 us-gaap Proceeds From Sale Of Real Estate Heldforinvestment
ProceedsFromSaleOfRealEstateHeldforinvestment
5826000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Real Estate Heldforinvestment
ProceedsFromSaleOfRealEstateHeldforinvestment
144361000 usd
CY2024Q1 us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
3392000 usd
CY2023Q1 us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
0 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-74829000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
114252000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
0 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
576946000 usd
CY2024Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
489000 usd
CY2023Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
163000 usd
CY2024Q1 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
0 usd
CY2023Q1 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
500000000 usd
CY2024Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1093000 usd
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
19856000 usd
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
13000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
46000 usd
CY2024Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
33154000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
33090000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-34749000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
23791000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-110504000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
150416000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
197830000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
45420000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
87326000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
195836000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
71287000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
180616000 usd
CY2024Q1 us-gaap Restricted Cash
RestrictedCash
16039000 usd
CY2023Q1 us-gaap Restricted Cash
RestrictedCash
15220000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
87326000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
195836000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
82664000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
91614000 usd
CY2024Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
115000 usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
37000 usd
CY2024Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
39705000 usd
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
10642000 usd
CY2024Q1 svc Ownership Percentage Held In Subsidiary
OwnershipPercentageHeldInSubsidiary
1
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:10pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect reported amounts. Actual results could differ from those estimates. Significant estimates in our condensed consolidated financial statements include the allowance for credit losses, purchase price allocations, useful lives of fixed assets and impairment of real estate and related intangibles.</span></div>
CY2024Q1 us-gaap Straight Line Rent Adjustments
StraightLineRentAdjustments
5768000 usd
CY2023Q1 us-gaap Straight Line Rent Adjustments
StraightLineRentAdjustments
-2448000 usd
CY2024Q1 svc Straight Line Rent Receivables
StraightLineRentReceivables
64151000 usd
CY2023Q4 svc Straight Line Rent Receivables
StraightLineRentReceivables
56833000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-78383000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
25950000 usd
CY2024Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
122000 usd
CY2023Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
117000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-78505000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
25833000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
165158000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
165158000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
164867000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
164867000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.48
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.48
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2024Q1 svc Real Estate Investment Property And Real Estate Held For Sale At Cost
RealEstateInvestmentPropertyAndRealEstateHeldForSaleAtCost
9825433000 usd
CY2024Q1 us-gaap Real Estate Heldforsale
RealEstateHeldforsale
10296000 usd
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
-665000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
-3540000 usd
CY2024Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
1537 shares
CY2024Q1 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
8.54
CY2024Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.20
CY2024Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
33154000 usd
CY2024Q1 us-gaap Nature Of Operations
NatureOfOperations
<div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 10. Business and Property Management Agreements with RMR</span></div><div style="margin-bottom:10pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have no employees. The personnel and various services we require to operate our business are provided to us by RMR. We have two agreements with RMR to provide management services to us: (1) a business management agreement, which relates to our business generally, and (2) a property management agreement, which relates to our property level operations of our net lease portfolio, the office building component of one of our hotels and major renovation or repositioning activities at our hotels that we may request RMR to manage from time to time. </span></div><div style="margin-bottom:10pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to our business management agreement with RMR, we recognized net business management fees of $7,757 and $8,385 for the three months ended March 31, 2024 and 2023, respectively. Based on our common share total return, as defined in our business management agreement, as of each of March 31, 2024 and 2023, no incentive fees are included in the net business management fees we recognized for the three months ended March 31, 2024 or 2023. The actual amount of annual incentive fees for 2024, if any, will be based on our common share total return, as defined in our business management agreement, for the three-year period ending December 31, 2024, and will be payable in January 2025. We did not incur an incentive fee payable to RMR for the year ended December 31, 2023. We include business management fee amounts in general and administrative expenses in our condensed consolidated statements of comprehensive income (loss). </span></div><div style="margin-bottom:10pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to our property management agreement with RMR, we recognized aggregate property management and construction supervision fees of $3,180 and $1,412 for the three months ended March 31, 2024 and 2023, respectively. Of those amounts, for the three months ended March 31, 2024 and 2023, $1,484 and $945, respectively, of property management fees were expensed to net lease operating expenses in our condensed consolidated statements of comprehensive income (loss) and $1,696 and $467, respectively, of construction and supervision fees were capitalized as building improvements in our condensed consolidated balance sheets. The amounts capitalized are being depreciated over the estimated useful lives of the related capital assets.</span></div><div style="margin-bottom:10pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are generally responsible for all of our operating expenses, including certain expenses incurred or arranged by RMR on our behalf. We are generally not responsible for payment of RMR’s employment, office or administrative expenses incurred to provide management services to us, except for the employment and related expenses of RMR employees assigned to work exclusively or partly at our net lease properties and the office building component of one of our hotels, our share of the wages, benefits and other related costs of RMR’s centralized accounting personnel, our share of RMR’s costs for providing our internal audit function, and as otherwise agreed. Our property level operating expenses are generally incorporated into rents charged to our tenants, including certain payroll and related costs incurred by RMR. We reimbursed RMR $1,094 and $1,003 for these expenses and costs for the three months ended March 31, 2024 and 2023, respectively. We included these amounts in net lease operating expenses and general and administrative expenses, as applicable, in our condensed consolidated statements of comprehensive income (loss).</span></div>
CY2024Q1 dei Entity Number Of Employees
EntityNumberOfEmployees
0 employee
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1007000 usd
CY2024Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
621000 usd
CY2024Q1 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
386000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3780000 usd
CY2023Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-2297000 usd
CY2023Q1 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
-1483000 usd
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
336236000 usd
CY2024Q1 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
100014000 usd
CY2024Q1 us-gaap Revenues
Revenues
436250000 usd
CY2024Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
305086000 usd
CY2024Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
4723000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
93107000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10506000 usd
CY2024Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
2451000 usd
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
415873000 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
-2963000 usd
CY2024Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
1962000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
91414000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-72038000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1007000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-5338000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-78383000 usd
CY2024Q1 us-gaap Assets
Assets
7231519000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
334796000 usd
CY2023Q1 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
94413000 usd
CY2023Q1 us-gaap Revenues
Revenues
429209000 usd
CY2023Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
299566000 usd
CY2023Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
3905000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
100039000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10911000 usd
CY2023Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
887000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
415308000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
41898000 usd
CY2023Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
49430000 usd
CY2023Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
2786000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
81580000 usd
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-44000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
26391000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3780000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-4221000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
25950000 usd
CY2023Q4 us-gaap Assets
Assets
7356116000 usd

Files In Submission

Name View Source Status
svc-20240331_cal.xml Edgar Link unprocessable
R43.htm Edgar Link pending
0000945394-24-000025-index-headers.html Edgar Link pending
0000945394-24-000025-index.html Edgar Link pending
0000945394-24-000025.txt Edgar Link pending
0000945394-24-000025-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
svc-20240331.htm Edgar Link pending
svc-20240331.xsd Edgar Link pending
svc-q12024xex101xfirstamen.htm Edgar Link pending
svc-q12024xex102xschedulex.htm Edgar Link pending
svc-q12024xex103schedulexs.htm Edgar Link pending
svc-q12024xex221subsidiary.htm Edgar Link pending
svc-q12024xex419x2024addit.htm Edgar Link pending
svc-q12024xex425x2024addit.htm Edgar Link pending
svc-q12024xex427x2024addit.htm Edgar Link pending
svc_033124x10qex311.htm Edgar Link pending
svc_033124x10qex312.htm Edgar Link pending
svc_033124x10qex313.htm Edgar Link pending
svc_033124x10qex314.htm Edgar Link pending
svc_033124x10qex321.htm Edgar Link pending
svc-20240331_def.xml Edgar Link unprocessable
svc-20240331_lab.xml Edgar Link unprocessable
svc-20240331_pre.xml Edgar Link unprocessable
svc-20240331_htm.xml Edgar Link completed